Keywords: zeltia, yondelis, enters, phase, iii, value, spanish

Zeltia's Yondelis enters Phase III

Article | 11 April 2005

Print This

The value of the Spanish Zeltia group rose 1.3% on the Madrid stock exchange after announcing that its ovarian cancer agent, ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in